Marketing - Press Releases

Date	Title	Company
22-Apr-2020	Futura files for Further Pre-Submission meeting with the FDA following receipt of its Phase 3 clinical study report	Futura Medical plc
22-Apr-2020	FoRx Therapeutics AG Raises EUR 10 Million Seed Round First Company to Develop a Pipeline of Drugs Targeting DNA Replication Stress for Cancer	FoRx Therapeutics
22-Apr-2020	NICE approves oral drug VITRAKVI®▼(larotrectinib), the first histology-independent treatment to be made available in England, for children and adults with TRK fusion driven cancer	Larotrectinib
22-Apr-2020	New name: H.C. Starck Tantalum & Niobium becomes TANIOBIS	TANIOBIS
22-Apr-2020	Targovax and Valo Therapeutics enter collaboration to develop RAS neoantigen coating of ONCOS viruses using PeptiCRAd technology	Targovax ASA
22-Apr-2020	Care homes tragedy needs to be wake-up call says NHS Confederation	NHS Confederation
22-Apr-2020	Eurofins Medical Device Testing commitment to support the safety and efficacy of devices used in the COVID-19 Crisis Response	Eurofins Medical
22-Apr-2020	Blue Earth Diagnostics Continues to Expand Access to Axumin® (fluciclovine (18F)) with First Commercial Supply in Slovakia, Europe	Blue Earth Diagnostics Ltd,
22-Apr-2020	Laboratory relocation firm offers free support for NHS	Aport
22-Apr-2020	Torx™ - a new web-based platform to keep chemists connected for faster quality candidate selection	Torx Software
22-Apr-2020	South Wales business secures £226 million from HSBC UK to support essential industries during Covid-19	HSBC UK
22-Apr-2020	Sobi™ affiliate Florio GmbH, launches a new digital platform aiming to improve the lives of people with haemophilia	Sobi
22-Apr-2020	Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting	Santhera Pharmaceuticals
21-Apr-2020	Automotive OLED Lighting Market to Decelerate in 2020 as COVID-19 Pandemic Takes its Toll on Global Market \| Long-term Outlook Remains Positive	Market Expertz
20-Apr-2020	Advent Life Sciences Continues Support of Innovation in Life Sciences with the Launch of Two New Cancer	Advent Life Sciences
20-Apr-2020	SCOTTISH MEDICINES CONSORTIUM (SMC) ACCEPTS STELARA® (USTEKINUMAB) FOR THE TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN SCOTLAND	The Janssen Pharmaceutical Companies of Johnson & Johnson
20-Apr-2020	Cegedim Supporting Patient Care during COVID-19	Cegedim
20-Apr-2020	Kromek to commence production of Metran-based ventilators for COVID-19 response	Kromek
20-Apr-2020	Sanofi and Luminostics to join forces on developing breakthrough COVID-19 smartphone-based self-testing solution	Sanofi
20-Apr-2020	STORM Therapeutics announces publication in Nature Reviews Cancer on the role of RNA Modifications in Cancer by Founder Professor Tony Kouzarides	STORM Therapeutics